CME Group vs. Intercontinental: Which Exchange Stock is a Better Buy?
Though both CME and ICE are Buy-rated stocks, let's find out which exchange stock is a better investment to generate sizable returns.
CME Group Announces First Trades of XRP Futures
CHICAGO , May 20, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced its new XRP futures are now available for trading. The first trade, a block, took place on Sunday, May 18, and was cleared by Hidden Road.
Is CME Group (CME) Stock Outpacing Its Finance Peers This Year?
Here is how CME Group (CME) and ACNB (ACNB) have performed compared to their sector so far this year.
CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders
CHICAGO , May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A.
CME Hits 52-Week High: Time to Buy Despite Expensive Valuation?
Let us delve deeper to find out what to do with CME stock now.
CME Group Declares Quarterly Dividend
CHICAGO , May 8, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a second-quarter dividend of $1.25 per share. The dividend is payable June 25, 2025 to shareholders of record as of June 9, 2025.
CME Group Sets New ADV Record of 35.9 Million Contracts In April, Up 36% Year Over Year
Interest rate ADV grew 46% to 18.4 million contracts Record monthly ADV in equity index and metals products Record monthly international ADV of 10.9 million contracts CHICAGO , May 2, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its April 2025 market statistics reached an all-time monthly average daily volume (ADV) record of 35.9 million contracts, an increase of 36% year-over-year. The company's interest rate ADV grew 46% to 18.4 million contracts in April, while its equity index and metals products set new monthly ADV records of 9.7 million contracts and 1 million contracts, respectively.
Is CME Group (CME) Outperforming Other Finance Stocks This Year?
Here is how CME Group (CME) and Banco De Chile (BCH) have performed compared to their sector so far this year.
CME Group: Risk Is Now The House Edge; CME Poised To Outroll Street
Initiate Strong Buy on CME Group with $332.96 PT; CME monetizes market disruption with record Q1 ADV and sustained speculative "risk-on" positioning. CME deserves a forward PE multiple of 29.5x for FY25E, driven by high-rate-fueled interest income and structural macro-vol, driving cross-asset product innovation. Above Street EPS for FY25/FY26E due to unmatched volume tailwinds, strategic catalysts, and capital-light tech investment, positioning CME for a breakout.
CME Group (CME) Is Up 1.44% in One Week: What You Should Know
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
CME Group: Expect Generous Dividends This Year
CME Group thrives on market volatility, earning revenue on every trade, making it resilient in both good and bad times. CME's niche in the derivatives market, international expansion, and product innovation drive growth, especially during uncertain times. Strong financials, including solid profit margins and high dividend payouts, make CME an attractive investment for income-focused investors.
CME: More Market Volatility Equals More Demands - Initiating With Strong Buy
Initiating a 'Strong Buy' rating for CME with a fair value of $301 per share due to increased demand for hedging amid economic uncertainty and market volatility. CME's diverse product offerings and strong trading volume growth, particularly in interest rate options/futures, equity, FX, energy, and commodities, support its robust business model. CME's high operating margin, capex-light business model, and strategic use of Google Cloud enhance profitability and operational efficiency.
